Maureen Jonas' research focuses on liver disease in children, with emphasis on viral hepatitis. She was the principal investigator in the
multicenter International Pediatric Lamivudine Trial, and is currently studying the safety and efficacy of other drugs, adefovir dipivoxil and
entecavir, in children with chronic hepatitis B. She is the principle site investigator for PEDS-C, an NIH sponsored study of the treatment of chronic hepatitis C in children. Other research involves looking at non-invasive ways to detect and measure fibrosis (scarring) in the liver, and some of the metabolic effects of chronic hepatitis C. She participates in an international epidemiologic study of hepatitis B in children, and the national Studies of Pediatric Liver Transplantation (SPLIT.)
About Maureen Jonas
Maureen Jonas received her MD degree from University of Miami School of
Medicine. She completed internship and residency in General Pediatrics,
and fellowship in Pediatric Gastroenterology, at Boston Children's Hospital. She is certified in Pediatric Gastroenterology and Pediatric
Dr. Jonas has served on the Executive Council of the North American
Society for Pediatric Gastroenterology, Hepatology and Nutrition
(NASPGHAN) and numerous committees of the American Association for the
Study of Liver Diseases. She is a member of the Medical Advisory
Committee of the New England Chapter of the American Liver Foundation.
She is the director of the Center for Childhood Liver Disease and the
Medical Director of the Liver Transplant Program at Boston Children’s Hospital. She is also the Director of the 4th year Advanced Hepatology Fellowship at Children’s. Dr. Jonas recently edited a book on Viral Hepatitis in Children.